Who is sponsoring NCT05493488?

NCT05493488 is sponsored by DermBiont, Inc..

What condition does NCT05493488 study?

NCT05493488 studies Tinea Pedis.

What drugs are being tested in NCT05493488?

Interventions: DBI-001 Gel, DBI-002 Gel, Aqueous Gel.

What is the status of NCT05493488?

NCT05493488 is currently UNKNOWN.

Last reviewed 2023-02-14 · How we verify

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

NCT05493488 PHASE2 UNKNOWN

This is a randomized, observer blinded, Aqueous Gel-controlled trial examining the effect of daily application for approximately 6-8 days of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel on the subjects with interdigital tinea pedis based on Whole Genome Sequencing (WGS) and Quantitative Polymerase Chain Reaction (qPCR), and comparison between Quantitative Polymerase Chain Reaction (qPCR) and Potassium Hydroxide (KOH) for the presence of Trichophyton rubrum (T.rubrum) as well as signs and symptoms and local tolerability and toxicity on treated sites in subjects.

Details

Lead sponsor	DermBiont, Inc.
Phase	PHASE2
Status	UNKNOWN
Enrolment	24
Start date	Thu Sep 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Tinea Pedis

Interventions

DBI-001 Gel
DBI-002 Gel
Aqueous Gel

Countries

United States